BioCentury | Apr 10, 2019
Distillery Therapeutics

Antibody-drug conjugate targeting ALK could treat neuroblastoma

...TARGET/MARKER/PATHWAY: Anaplastic lymphoma kinase (ALK) LICENSING STATUS: Patented; licensed to Celldex Therapeutics Inc. PUBLICATION DETAILS: Sano...
BioCentury | Mar 9, 2018
Company News

DNDi, partners aim to bring cheaper HCV combo to Latin America

...Argentina) will register, manufacture and distribute the compounds in Latin America. DNDi and non-profit Mundo Sano...
...Neglected Diseases initiative, Geneva, Switzerland Insud Pharma, Madrid, Spain Laboratorio Elea Phoenix S.A., Argentina Mundo Sano...
...Infectious Jennie Walters ravidasvir (ASC16, PPI-668) Sovaldi, sofosbuvir (GS-7977, psi-7977) Drugs for Neglected Diseases initiative (DNDi) Gilead Sciences Inc. Insud Pharma Mundo Sano...
BioCentury | Mar 7, 2018
Company News

DNDi, partners aim to bring cheaper HCV combo to Latin America

...will register, manufacture and distribute the compounds in Latin America. DNDi and non-profit foundation Mundo Sano...
...NS5A protein inhibitor. Jennie Walters ravidasvir (ASC16, PPI-668) Sovaldi, sofosbuvir (GS-7977, psi-7977) Drugs for Neglected Diseases initiative (DNDi) Insud Pharma Mundo Sano Pharco...
BioCentury | Sep 1, 2017
Clinical News

FDA approves Chemo's Chagas treatment

...less than $950, and potentially less than $50 under a patient assistance program. Chemo, Mundo Sano...
...USA Inc. division will distribute benznidazole in the U.S. Chemo Group , Barcelona, Spain Mundo Sano...
...DNDi) , Geneva, Switzerland Product: Benznidazole Business: Infectious Chris Lieu Chemo Group Drugs for Neglected Diseases initiative (DNDi) Mundo Sano...
BioCentury | Dec 22, 2016
Product R&D

Fever pace for Zika

...Novavax Inc. ( NASDAQ:NVAX) Undisclosed vaccine Preclinical Protein Sciences Corp. ; Sinergium Biotech ; ArgentinaMundo Sano...
BioCentury | Apr 25, 2016
Company News

Protein Sciences, Sinergium, Mundo Sano deal

...be reached. Protein Sciences Corp. , Meriden, Conn. Sinergium Biotech , Buenos Aires, Argentina Mundo Sano...
BioCentury | Apr 15, 2013
Clinical News

Nicotine/mecamylamine transdermal patch data

...decline in craving by self-report. Phase III testing is underway with results expected this year, SANO...
...first two weeks. Increase in abstinence at one week following quitting also was reported. Sano Corp. (SANO...
BioCentury | Feb 7, 2013
Cover Story

2012 gets a new deal

...Bill & Melinda Gates Foundation; Drugs for Neglected Diseases initiative; Lions Clubs International Foundation; Mundo Sano...
BioCentury | Feb 6, 2012
Company News

Becton Dickinson, Gilead, Abbott, AstraZeneca, Bayer, Bristol-Myers, Eisai, GlaxoSmithKline, J&J, Merck, Merck KGaA, Novartis, Pfizer, Sanofi infectious news

...for Neglected Diseases initiative (DNDi) (Geneva, Switzerland); Lions Clubs International Foundation (Oak Brook, Ill.); Mundo Sano...
BioCentury | Jan 2, 2006
Finance

Profiling Perlegen's money

...Capital; Mizuho Securities; Glynn Capital Management; Cape Securities; Maverick Capital; Lombard Odier; Zesiger Capital Group; Sano...
Items per page:
1 - 10 of 33
BioCentury | Apr 10, 2019
Distillery Therapeutics

Antibody-drug conjugate targeting ALK could treat neuroblastoma

...TARGET/MARKER/PATHWAY: Anaplastic lymphoma kinase (ALK) LICENSING STATUS: Patented; licensed to Celldex Therapeutics Inc. PUBLICATION DETAILS: Sano...
BioCentury | Mar 9, 2018
Company News

DNDi, partners aim to bring cheaper HCV combo to Latin America

...Argentina) will register, manufacture and distribute the compounds in Latin America. DNDi and non-profit Mundo Sano...
...Neglected Diseases initiative, Geneva, Switzerland Insud Pharma, Madrid, Spain Laboratorio Elea Phoenix S.A., Argentina Mundo Sano...
...Infectious Jennie Walters ravidasvir (ASC16, PPI-668) Sovaldi, sofosbuvir (GS-7977, psi-7977) Drugs for Neglected Diseases initiative (DNDi) Gilead Sciences Inc. Insud Pharma Mundo Sano...
BioCentury | Mar 7, 2018
Company News

DNDi, partners aim to bring cheaper HCV combo to Latin America

...will register, manufacture and distribute the compounds in Latin America. DNDi and non-profit foundation Mundo Sano...
...NS5A protein inhibitor. Jennie Walters ravidasvir (ASC16, PPI-668) Sovaldi, sofosbuvir (GS-7977, psi-7977) Drugs for Neglected Diseases initiative (DNDi) Insud Pharma Mundo Sano Pharco...
BioCentury | Sep 1, 2017
Clinical News

FDA approves Chemo's Chagas treatment

...less than $950, and potentially less than $50 under a patient assistance program. Chemo, Mundo Sano...
...USA Inc. division will distribute benznidazole in the U.S. Chemo Group , Barcelona, Spain Mundo Sano...
...DNDi) , Geneva, Switzerland Product: Benznidazole Business: Infectious Chris Lieu Chemo Group Drugs for Neglected Diseases initiative (DNDi) Mundo Sano...
BioCentury | Dec 22, 2016
Product R&D

Fever pace for Zika

...Novavax Inc. ( NASDAQ:NVAX) Undisclosed vaccine Preclinical Protein Sciences Corp. ; Sinergium Biotech ; ArgentinaMundo Sano...
BioCentury | Apr 25, 2016
Company News

Protein Sciences, Sinergium, Mundo Sano deal

...be reached. Protein Sciences Corp. , Meriden, Conn. Sinergium Biotech , Buenos Aires, Argentina Mundo Sano...
BioCentury | Apr 15, 2013
Clinical News

Nicotine/mecamylamine transdermal patch data

...decline in craving by self-report. Phase III testing is underway with results expected this year, SANO...
...first two weeks. Increase in abstinence at one week following quitting also was reported. Sano Corp. (SANO...
BioCentury | Feb 7, 2013
Cover Story

2012 gets a new deal

...Bill & Melinda Gates Foundation; Drugs for Neglected Diseases initiative; Lions Clubs International Foundation; Mundo Sano...
BioCentury | Feb 6, 2012
Company News

Becton Dickinson, Gilead, Abbott, AstraZeneca, Bayer, Bristol-Myers, Eisai, GlaxoSmithKline, J&J, Merck, Merck KGaA, Novartis, Pfizer, Sanofi infectious news

...for Neglected Diseases initiative (DNDi) (Geneva, Switzerland); Lions Clubs International Foundation (Oak Brook, Ill.); Mundo Sano...
BioCentury | Jan 2, 2006
Finance

Profiling Perlegen's money

...Capital; Mizuho Securities; Glynn Capital Management; Cape Securities; Maverick Capital; Lombard Odier; Zesiger Capital Group; Sano...
Items per page:
1 - 10 of 33